Cargando…

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes

Clonal mast cell activation syndromes and indolent systemic mastocytosis without skin involvement are two emerging entities that sometimes might be clinically difficult to distinguish, and they involve a great challenge for the physician from both a diagnostic and a therapeutic point of view. Furthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-de-Olano, David, Matito, Almudena, Orfao, Alberto, Escribano, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112577/ https://www.ncbi.nlm.nih.gov/pubmed/27909577 http://dx.doi.org/10.12688/f1000research.9565.1

Ejemplares similares

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features
por: Rama, Tiago Azenha, et al.
Publicado: (2022)

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis
por: Dasilva-Freire, Noelia, et al.
Publicado: (2019)

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature
por: Alvarez-Twose, Iván, et al.
Publicado: (2016)

Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome
por: Matito, Almudena, et al.
Publicado: (2013)

Insights in Anaphylaxis and Clonal Mast Cell Disorders
por: González-de-Olano, David, et al.
Publicado: (2017)

Recent advances in the understanding and therapeutic management of mastocytosis
por: Rossignol, Julien, et al.
Publicado: (2019)

Altered innate immune profile in blood of systemic mastocytosis patients
por: Pérez‐Pons, Alba, et al.
Publicado: (2022)

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
por: Giannetti, Matthew P., et al.
Publicado: (2021)

Hodgkin’s lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis
por: Gasljevic, Gorana, et al.
Publicado: (2015)

Fatal Hymenoptera Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?
por: Rijavec, Matija, et al.
Publicado: (2023)

Mastocytosis and Mast Cell Activation Disorders: Clearing the Air
por: Jackson, Clayton Webster, et al.
Publicado: (2021)

Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis
por: KWIATKOWSKA, Dominika, et al.
Publicado: (2021)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with clonal mast cell disorders
por: Ruano-Zaragoza, Maria, et al.
Publicado: (2022)

Recent advances in mast cell clonality and anaphylaxis
por: Akin, Cem
Publicado: (2009)

Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis
por: González-López, Oscar, et al.
Publicado: (2022)

Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
por: Tran, Tu M., et al.
Publicado: (2020)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
por: Gülen, Theo
Publicado: (2023)

Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
por: Schmidt, Tobias Jürgen, et al.
Publicado: (2022)

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
por: Valent, Peter, et al.
Publicado: (2023)

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
por: Jawhar, Mohamad, et al.
Publicado: (2019)

A Rare Case of Systemic Mastocytosis With Associated Clonal Hematological Non-Mast Cell Lineage Disease That Transformed to Acute Leukemia With IDH2 Mutation
por: Liman, Andrew D., et al.
Publicado: (2020)

Correction : Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
por: Schmidt, Tobias Jürgen, et al.
Publicado: (2023)

Mast Cell Clonal Disorders: Classification, Diagnosis and Management
por: Onnes, Merel C., et al.
Publicado: (2016)

Indolent systemic mastocytosis and aleukemic mast cell leukemia: Subtle diagnostic differences with distinct management approaches
por: Paiva, Marcelo L., et al.
Publicado: (2023)

Evolution of myelodisplasic syndrome with ring sideroblasts (MDS-RS) to systemic mastocytosis and aleukemic mast cell leukemia
por: Costa, Larissa da, et al.
Publicado: (2020)

Clinical potential of midostaurin in advanced systemic mastocytosis
por: Chandesris, Marie Olivia, et al.
Publicado: (2017)

Systemic mastocytosis presenting as cardiac tamponade with CD25(+) pericardial mast cells
por: Sukrithan, Vineeth K., et al.
Publicado: (2016)

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
por: Lyberg, Katarina, et al.
Publicado: (2022)

ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
por: Damaj, Gandhi, et al.
Publicado: (2014)

Comparing histamine intolerance and non-clonal mast cell activation syndrome
por: Cimolai, Nevio
Publicado: (2020)

Acute Myeloid Leukemia with Occult Systemic Mastocytosis or Atypical Mast Cells Post-induction
por: Khan, Salahuddin, et al.
Publicado: (2018)

Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
por: El Hussein, Siba, et al.
Publicado: (2022)

Treatment of Indolent and Advanced Systemic Mastocytosis
por: Buonomo, Alessandro, et al.
Publicado: (2022)

Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle‐shaped mast cells in bone marrow
por: Spolak‐Bobryk, Natalia, et al.
Publicado: (2022)

Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation
por: Altohami, Mohammed O. A., et al.
Publicado: (2021)

A unique presentation of pulmonary disease in advanced systemic mastocytosis, proven by the presence of mast cells in bronchoalveolar lavage: a case report
por: Hermans, Maud A. W., et al.
Publicado: (2016)

Prostaglandin D(2) metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis
por: Cho, Catherine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_75nu4ms8c10afbp34qlq0ckq8l